advertisement

Prostate cancer

07 December 2010

Study Backs 'Active Surveillance' for Low-Risk Prostate Cancer

But the alternative to immediate treatment isn't for all men, researchers say

This article has not necessarily been edited by Health24.

"The intent of this study is to show that, on average, showing average disease-recurrence probabilities, an average rate of side effects and average individual preferences, active surveillance was an option," said Dr. Julia H. Hayes, lead author of the study published in the Dec. 1 issue of the Journal of the American Medical Association.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.